Global Absorbable Hemostat Market Growth 2024-2030
Absorbable Hemostat: Valued at US$ 21.47 billion in 2023, projected to reach US$ 31.45 billion by 2030, with a 5.6% CAGR, fueled by increasing demand in the downstream market.
According to Publisher’s latest study, the global Absorbable Hemostat market size was valued at US$ 21470 million in 2023. With the growing demand in the downstream market, the Absorbable Hemostat is forecast to have a readjusted size of US$ 31450 million by 2030 with a CAGR of 5.6% during the review period.
Market Overview
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
The research report highlights the growth potential of the global Absorbable Hemostat market. Absorbable Hemostats are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Absorbable Hemostat. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Absorbable Hemostat market. Absorbable hemostatic material is a kind of biomedical material that can be used to stop bleeding quickly and be absorbed by the human body within a certain period.
Key Features:
The report on the Absorbable Hemostat market reflects various aspects and provides valuable insights into the industry.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
Market Drivers: Chronic Disease Prevalence: The rise in chronic illnesses drives the need for surgical procedures, which increases the market for absorbable hemostats. By helping to control bleeding issues during procedures, these hemostatic medicines improve patient outcomes.
Minimally Invasive Surgery: As these procedures become more common, there is a growing need for absorbable hemostats that work well with them. The market is growing because hemostatic agents that guarantee quick hemostasis and less tissue damage are chosen.
Ageing Population: Especially among the elderly, the ageing global population is a factor in the rising need for surgical treatments. This market is growing because absorbable hemostats are essential for controlling bleeding issues in this population.
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Challenges- Regulatory Compliance: Manufacturers face difficulties in getting clearance and meeting strict regulations. Time-to-market and expenses are increased by the need for lengthy clinical trials and documentation to comply with safety, effectiveness, and quality standards.
Cost Restrictions: Reimbursement issues and price sensitivity among healthcare providers prevent the market from expanding. Adoption may be hampered by absorbable hemostats' expensive price, particularly in healthcare settings where money is tight.
Competition from Alternatives: There are difficulties when dealing with competition from topical medications and mechanical hemostats, two types of alternative hemostatic treatments. To be competitive, market competitors need to set their products apart concerning their efficacy, safety, and convenience of use.
Market Forecasts and Future Outlook: Technological Innovation: Ongoing R&D expenditures to create cutting-edge hemostatic technology and meet unmet clinical requirements. Market Expansion: To take advantage of the rising demand for absorbable hemostats, enter emerging markets and form strategic alliances. Affordable Solutions: Creating affordable absorbable hemostats to increase accessibility is important, especially in healthcare settings with limited resources.
Opportunities: Technological Advancements: Market participants have the chance to innovate and launch cutting-edge hemostatic technologies by continuing to invest in research and development. The effectiveness and adaptability of absorbable hemostats can be improved by the development of innovative biomaterials, tailored delivery methods, and combination therapies, meeting a range of surgical requirements and increasing market potential.
Market Expansion: Opportunities for expansion and market diversification arise from entering emerging markets, especially those in Asia-Pacific and Latin America. A climate that is favourable for market penetration and expansion is produced in these locations by rising investments in healthcare infrastructure, a rise in surgery volumes, and improved access to healthcare services.
Market Segmentation:
The Absorbable Hemostat market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. In terms of product, gauze is the largest segment, with a share of over 40%. In terms of application, the largest application is hospitals, followed by clinics, etc.
1. Segmentation by type
• Gauze
• Powder
• Gelatin Sponge
• Other
2. Segmentation by application
• Hospital
• Clinics
• Other
Regional Insights: America: Leading the world's absorbable hemostat market, America is dominated by major players and has a sophisticated healthcare infrastructure. Market expansion is facilitated by advantageous reimbursement policies and technological improvements. Europe: Due to strict regulatory requirements and a growing uptake of cutting-edge surgical methods, Europe is a sizable market. The UK and Germany are two important nations that support market expansion. Asia-Pacific: Growing surgical volumes and an expanding healthcare infrastructure are driving the region's fast market expansion. Paying chances for market expansion are abundant in emerging markets such as China and India. Europe is the largest production market, with a share of over 35%, followed by North America, and Japan, the total has a share of about 40 per cent.
1. Americas
• United States
• Canada
• Mexico
• Brazil
2. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
3. Europe
• Germany
• France
• UK
• Italy
• Russia
4. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries
Competitive Landscape- Global absorbable hemostatic key players include Curasan AG, Johnson & Johnson, Cura Medical, GELITA MEDICAL, B.Braun, etc. Global top five manufacturers hold a production share of over 35%. The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, and market penetration.
• Johnson & Johnson
• BD
• Baxter
• B.Braun
• Cura Medical
• GELITA MEDICAL
• Curasan AG
• Meril Life Sciences
• Zhonghui Shengxi
• Beijing Datsing Biotech
• Guizhou Jin Jiu Biotech
• Beijing Taikesiman
• Foryou Medical
• Saikesaisi Holdings Group
• Biotemed
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Absorbable Hemostat Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Absorbable Hemostat by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Absorbable Hemostat by Country/Region, 2019, 2023 & 2030
2.2 Absorbable Hemostat Segment by Type
2.2.1 Gauze
2.2.2 Powder
2.2.3 Gelatin Sponge
2.2.4 Other
2.3 Absorbable Hemostat Sales by Type
2.3.1 Global Absorbable Hemostat Sales Market Share by Type (2019-2024)
2.3.2 Global Absorbable Hemostat Revenue and Market Share by Type (2019-2024)
2.3.3 Global Absorbable Hemostat Sale Price by Type (2019-2024)
2.4 Absorbable Hemostat Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Other
2.5 Absorbable Hemostat Sales by Application
2.5.1 Global Absorbable Hemostat Sale Market Share by Application (2019-2024)
2.5.2 Global Absorbable Hemostat Revenue and Market Share by Application (2019-2024)
2.5.3 Global Absorbable Hemostat Sale Price by Application (2019-2024)
3 Global Absorbable Hemostat by Company
3.1 Global Absorbable Hemostat Breakdown Data by Company
3.1.1 Global Absorbable Hemostat Annual Sales by Company (2019-2024)
3.1.2 Global Absorbable Hemostat Sales Market Share by Company (2019-2024)
3.2 Global Absorbable Hemostat Annual Revenue by Company (2019-2024)
3.2.1 Global Absorbable Hemostat Revenue by Company (2019-2024)
3.2.2 Global Absorbable Hemostat Revenue Market Share by Company (2019-2024)
3.3 Global Absorbable Hemostat Sale Price by Company
3.4 Key Manufacturers Absorbable Hemostat Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Absorbable Hemostat Product Location Distribution
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More